References
- Rivellese AA, Annuzzi G, Capaldo B, Vaccaro O, Riccardi G. Nutrizione Umana. 1st ed. Italy: Ildelson Gnocchi; 2017.
- Dalgleish AG, O’Byrne K. Inflammation and cancer: the role of the immune response and angiogenesis. Boston, MA: Springer Science; 2006. pp. 1–48.
- Betiati D. d S B, de Oliveira PF, Camargo C. d Q, Nunes EA, Trindade E. B S d M. Effects of omega-3 fatty acids on regulatory T cells in hematologic neoplasms. Rev Bras Hematol Hemoter. 2013;35(2):119–25. doi:https://doi.org/10.5581/1516-8484.20130033
- Acids UF. Nutritional and physiological significance. London: Chapman and Hall; 1992. The Report of the British Nutrition Foundation’s Task Force.
- Moreno JJ. Differential effects of arachidonic and eicosapentaenoic Acid-derived eicosanoids on polymorphonuclear transmigration across endothelial cell cultures. J Pharmacol Exp Ther. 2009;331(3):1111–7. doi:https://doi.org/10.1124/jpet.109.157891
- Loew A, Köhnke T, Rehbeil E, Pietzner A, Weylandt KH. A role for lipid mediators in acute myeloid leukemia. Int J Mol Sci. 2019;20(10):2425. doi:https://doi.org/10.3390/ijms20102425
- Thapa B, Rogers HJ. Cancer, myeloproliferative neoplasms. Treasure Island (FL): StatPearls Publishing, 2020.
- Storniolo CE, Cabral M, Busquets MA, Martín-Venegas R, Moreno JJ. Dual behavior of long-chain fatty acids and their cyclooxygenase/lipoxygenase metabolites on human intestinal caco-2 cell growth. Front Pharmacol. 2020;11:529976. doi:https://doi.org/10.3389/fphar.2020.529976
- Cabral M, Martín-Venegas R, Moreno JJ. Differential cell growth/apoptosis behavior of 13-hydroxyoctadecadienoic acid enantiomers in a colorectal cancer cell line. Am J Physiol Gastrointest Liver Physiol. 2014;307(6):664–71.
- Cabral M, Martín-Venegas R, Moreno JJ. Role of arachidonic acid metabolites on the control of non-differentiated intestinal epithelial cell growth. Int J Biochem Cell Biol. 2013;45(8):1620–8. doi:https://doi.org/10.1016/j.biocel.2013.05.009
- Kreitz J, Schönfeld C, Seibert M, Stolp V, Alshamleh I. Metabolic Plasticity of Acute Myeloid Leukemia. Cells. 2019;8:805. doi:https://doi.org/10.3390/cells8080805
- Rozovski U, Hazan-Halevy I, Barzilai M, Keating MJ, Estrov Z. Metabolism pathways in chronic lymphocytic leukemia. Leuk Lymphoma. 2016;57(4):758–65. doi:https://doi.org/10.3109/10428194.2015.1106533
- Mai A, Massa S, Rotili D, Cerbara I, Valente S, Pezzi R, Simeoni S, Ragno R. Histone deacetylation in epigenetics: An attractive target for anticancer therapy. Med Res Rev. 2005;25(3):261–309. doi:https://doi.org/10.1002/med.20024
- Jia X, Zheng Y, Guo Y, Chen K. Sodium butyrate and panobinostat induce apoptosis of chronic myeloid leukemia cells via multiple pathways. Mol Genet Genomic Med. 2019;7(5):e613. doi:https://doi.org/10.1002/mgg3.613
- Yamasaki M, Motonaga C, Yokoyama M, Ikezaki A, Kakihara T, Hayasegawa R, Yamasaki K, Sakono M, Sakakibara Y, Suiko M, et al. Induction of apoptotic cell death in HL-60 cells by jacaranda seed oil derived fatty acids. J Oleo Sci. 2013;62(11):925–32. : doi:https://doi.org/10.5650/jos.62.925
- Iuchi K, Ema M, Sozuki M, Yokoyama C, Hisatomi H. Oxidized unsaturated fatty acids induce apoptotic cell death in cultured cells. Mol Med Rep. 2019;19:2767–73.
- Finch ER, Kudva AK, Quickel MD, Goodfield LL, Kennett MJ, Whelan J, Paulson RF, Prabhu KS. Chemopreventive effects of dietary eicosapentaenoic acid supplementation in experimental myeloid leukemia. Cancer Prev Res (Phila)). 2015;8(10):989–99. doi:https://doi.org/10.1158/1940-6207.CAPR-15-0050
- Moustaka M, Maleskou E, Lambrianidou A, Papadopoulos S, Lekka ME, Trangas T, Kitsiouli E. Docosahexaenoic acid inhibits proliferation of EoL-1 leukemia cells and induces cell cycle arrest and cell differentiation. Nutrients. 2019;11 (3) :574. doi:https://doi.org/10.3390/nu11030574
- Sam MR, Esmaeillou M, Shokrgozar MA. Fish-oil-derived DHA-mediated enhancement of apoptosis in acute lymphoblastic leukemia cells is associated with accumulation of p53, downregulation of survivin, and Caspase-3 activation. Nutr Cancer. 2017;69 (1) :64–73. doi:https://doi.org/10.1080/01635581.2017.1247884
- Sam MR, Esmaeillou M, Sam S, Shokrgozar M. Fish-oil-derived eicosapentaenoic acid decreases survivin expression and induces wt-p53 accumulation with caspase-3 activation in acute lymphoblastic leukemia cells. Hum Exp Toxicol. 2018;37 (7):714–24. doi:https://doi.org/10.1177/0960327117730879
- Wang LW, Wang Z, Ersing I, Nobre L, Guo R, Jiang S, Trudeau S, Zhao B, Weekes MP, Gewurz BE, et al. E. Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival. PLoS Pathog. 2019;15(9):e1008030: doi:https://doi.org/10.1371/journal.ppat.1008030
- Chiu Y-H, Bertrand KA, Zhang S, Laden F, Epstein MM, Rosner BA, Chiuve S, Campos H, Giovannucci EL, Chavarro JE, et al. A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma. Int J Cancer. 2018;143(8):1914–22.: doi:https://doi.org/10.1002/ijc.31602
- Calder PC: Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta. 2015;1851(4):469–84. doi:https://doi.org/10.1016/j.bbalip.2014.08.010
- Bertrand KA, Giovannucci E, Rosner BA, Zhang SM, Laden F, Birmann BM. Dietary fat intake and risk of non-Hodgkin lymphoma in 2 large prospective cohorts. Am J Clin Nutr. 2017;106(2):650–6. doi:https://doi.org/10.3945/ajcn.117.155010
- Purdue MP, Bassani DG, Klar NS, Sloan M, Kreiger N, Canadian Cancer Registries Epidemiology Research Group. Canadian cancer registries epidemiology research group: dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2004;13(10):1665–76.
- Chang ET, Balter KM, Torrang A, Smedby KE, Melbye M, Sundstrom C, Glimelius B, Adami HO. Nutrient intake and risk of non-Hodgkin’s lymphoma. Am J Epidemiol. 2006;164(12):1222–32. doi:https://doi.org/10.1093/aje/kwj330
- Solimini AG, Lombardi AM, Palazzo C, De Giusti M. Meat intake and non-Hodgkin lymphoma: a meta-analysis of observational studies. Cancer Causes Control. 2016;27(5):595–606. doi:https://doi.org/10.1007/s10552-016-0745-2
- Astakhova L, Ngara M, Babich O, Prosekov A, Asyakina L, Dyshlyuk L, Midtvedt T, Zhou X, Ernberg I, Matskova L, et al. Short chain fatty acids (SCFA) reprogram gene expression in human malignant epithelial and lymphoid cells. PLoS One. 2016;11(7):e0154102: doi:https://doi.org/10.1371/journal.pone.0154102
- Jeffery IB, O’Toole PW. Diet-microbiota interactions and their implications for healthy living. Nutrients. 2013;5(1):234–52. doi:https://doi.org/10.3390/nu5010234
- Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341–52. doi:https://doi.org/10.1038/nri.2016.42
- Dorrestein PC, Mazmanian SK, Knight R. Finding the missing links among metabolites, microbes, and the host. Immunity. 2014;40(6):824–32. doi:https://doi.org/10.1016/j.immuni.2014.05.015
- Matanoski G, Tao X, Almon L, Adade AA, Davies-Cole JO. Demographics and tumor characteristics of colorectal cancers in the United States, 1998-2001. Cancer. 2006;107(5 Suppl):1112–20. doi:https://doi.org/10.1002/cncr.22008
- O’Keefe SJD, Li JV, Lahti L, Ou J, Carbonero F, Mohammed K, Posma JM, Kinross J, Wahl E, Ruder E, et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun. 2015;6(1):6342.,.: doi:https://doi.org/10.1038/ncomms7342
- Bindels LB, Neyrinck AM, Salazar N, et al. Non digestible oligosaccharides modulate the gut microbiota to control the development of leukemia and associated cachexia in mice. PLoS One. 2015;10:1–16. doi:https://doi.org/10.1371/journal.pone.0131009
- Bindels LB, Neyrinck AM, Claus SP, Le Roy CI, Grangette C, Pot B, Martinez I, Walter J, Cani PD, Delzenne NM, et al. Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia. Isme J. 2016;10(6):1456–70.: doi:https://doi.org/10.1038/ismej.2015.209
- Chagas TR, Borges DS, de Oliveira PF, Mocellin MC, Barbosa AM, Camargo CQ, Del Moral JÂG, Poli A, Calder PC, Trindade EBSM, et al. Oral fish oil positively influences nutritional-inflammatory risk in patients with haematological malignancies during chemotherapy with an impact on long-term survival: a randomised clinical trial. J Hum Nutr Diet. 2017;30(6):681–92. : doi:https://doi.org/10.1111/jhn.12471
- Cai Q, Huang H, Qian D, Chen K, Luo J, Tian Y, Lin T, Lin T. 13-methyltetradecanoic acid exhibits anti-tumor activity on T-cell lymphomas in vitro and in vivo by down-regulating p-AKT and activating caspase-3. PLoS One. 2013;8(6):e65308. doi:https://doi.org/10.1371/journal.pone.0065308
- Jurczyszyn A, Czepiel J, Gdula-Argasińska J, Paśko P, Czapkiewicz A, Librowski T, Perucki W, Butrym A, Castillo JJ, Skotnicki AB. Plasma fatty acid profile in multiple myeloma patients. Leuk Res. 2015;39(4):400–5. doi:https://doi.org/10.1016/j.leukres.2014.12.010
- Shao J, Wang H, Yuan G, Chen Z, Li Q. Involvement of the arachidonic acid cytochrome P450 epoxygenase pathway in the proliferation and invasion of human multiple myeloma cells. PeerJ. 2016;4:1–16 doi:https://doi.org/10.7717/peerj.1925
- Abdi J, Garssen J, Faber J, Redegeld AF. Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells. J Nutr Biochem. 2014;25(12):254–62.
- Rizzieri D, Paul B, Kang Y. Metabolic alterations and the potential for targeting metabolic pathways in the treatment of multiple myeloma. J Cancer Metastasis Treat. 2019;5:1–21 doi:https://doi.org/10.20517/2394-4722.2019.05
- Berge K, Tronstad KJ, Bohov P, Madsen L, Berge RK. Impact of mitochondrial beta-oxidation in fatty acid-mediated inhibition of glioma cell proliferation. J Lipid Res. 2003;44(1):118–27. doi:https://doi.org/10.1194/jlr.m200312-jlr200
- Gong Y, Dou L-J, Liang J. Link between obesity and cancer: role of triglyceride/free fatty acid cycling. Eur Rev Med Pharmacol Sci. 2014;18(19):2808–20.
- Bullwinkle EM, Parker MD, Bonan NF, Falkenberg LG, Davison SP, DeCicco-Skinner KL. Adipocytes contribute to the growth and progression of multiple myeloma: unraveling obesity related differences in adipocyte signaling. Cancer Lett. 2016;380(1):114–21. doi:https://doi.org/10.1016/j.canlet.2016.06.010
- Masarwi M, DeSchiffart A, Ham J, Reagan MR. Multiple Myeloma and Fatty Acid Metabolism. JBMR Plus. 2019;3(3):e10173. doi:https://doi.org/10.1002/jbm4.10173
- Falank C, Fairfield H, Reagan MR. Signaling interplay between bone marrow adipose tissue and multiple myeloma cells. Front in Endo. 2016;7:67.
- Dai X, Li M, Geng F. Omega-3 polyunsaturated fatty acids eicosapentaenoic acid and docosahexaenoic acid enhance dexamethasone sensitivity in multiple myeloma cells by the p53/miR-34a/Bcl-2 Axis. Biochemistry (Mosc)). 2017;82(7):826–33. doi:https://doi.org/10.1134/S0006297917070082
- D’Eliseo D, Renzo Santoni DL, Velotti A. F: Docosahexaenoic acid (DHA) promotes immunogenic apoptosis in human multiple myeloma cells, induces autophagy and inhibits STAT3 in both tumor and dendritic cells. Gen & Canc. 2017;8(1-2):426–37.
- Shinohara H, Sugito N, Kuranaga Y, Heishima K, Minami Y, Naoe T, Akao Y. Potent antiproliferative effect of fatty-acid derivative AIC-47 on leukemic mice harboring BCR-ABL mutation. Cancer Sci. 2019;110(2):751–60. doi:https://doi.org/10.1111/cas.13913
- Charbonneau B, O’Connor HM, Wang AH, Liebow M, Thompson CA, Fredericksen ZS, Macon WR, Slager SL, Call TG, Habermann TM, et al. Trans fatty acid intake is associated with increased risk and n3 fatty acid intake with reduced risk of non-hodgkin lymphoma. J Nutr. 2013;143(5):672–81. doi:https://doi.org/10.3945/jn.112.168658
- Elbarbary NS, Ismail EAR, Farahat RK, El-Hamamsy M. ω-3 Fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: a randomized placebo-controlled study. Nutrition. 2016;32(1):41–7. doi:https://doi.org/10.1016/j.nut.2015.06.010
- Drott K, Hagberg H, Papworth K, Relander T, Jerkeman M. Valproate in combination with rituximab and CHOP as first-line therapy in diffuse large B-cell lymphoma (VALFRID). Blood Adv. 2018;2(12):1386–92. doi:https://doi.org/10.1182/bloodadvances.2018019240
- Maschio M, Zarabla A, Maialetti A, Marchesi F, Giannarelli D, Gumenyuk S, Pisani F, Renzi D, Galiè E, Mengarelli A. Prevention of Bortezomib-related peripheral neuropathy with docosahexaenoic acid and α-lipoic acid in patients with multiple myeloma: preliminary data. Integr Cancer Ther. 2018;17(4):1115–24. doi:https://doi.org/10.1177/1534735418803758
- Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November, 1997. Hematol J. 2000;1(1):53–66. doi:https://doi.org/10.1038/sj.thj.6200013
- Mishra RK, Ahmad A, Vyawahare A, Kumar A, Khan R. Understanding the monoclonal antibody involvement in targeting the activation of tumor suppressor genes. Curr Top Med Chem. 2020;20(20):1810–23. doi:https://doi.org/10.2174/1568026620666200616133814
- Lamble AJ, Kosaka Y, Laderas T, Maffit A, Kaempf A. Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia. Proc Natl Acad Sci USA. 2019;8:201916206.
- Minervini A, Coccaro N, Anelli L, Zagaria A, Specchia G, et al. HMGA Proteins in hematological malignancies. Cancers (Basel. 2020;12(6):E1456. doi:https://doi.org/10.3390/cancers12061456
- Vitkeviciene A, Baksiene S, Borutinskaite V, Navakauskiene R. Epigallocatechin-3-gallate and BIX-01294 have different impact on epigenetics and senescence modulation in acute and chronic myeloid leukemia cells . Eur J Pharmacol. 2018;838:32–40. doi:https://doi.org/10.1016/j.ejphar.2018.09.005
- Cerrano M, Ruella M, Perales M, Vitale C, Faraci DG, et al. The advent of CAR T-Cell therapy for lymphoproliferative neoplasms: integrating research into clinical practice. Front Immunol. 2020;12:11–888.:
- Fraietta JA, Beckwith KA, Patel PR, Ruella M, Zheng Z, Barrett DM, Lacey SF, Melenhorst JJ, McGettigan SE, Cook DR, et al. Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia. Blood. 2016;127(9):1117–27.: doi:https://doi.org/10.1182/blood-2015-11-679134
- Fang X, Ge K, Song C, Ge Y, Zhang J. Biochemical and biophysical research communications effects of n-3PUFAs on autophagy and inflammation of hypothalamus and body weight in mice. Biochem Biophys Res Commun. 2018;501(4):927–32. doi:https://doi.org/10.1016/j.bbrc.2018.05.084
- Khaddaj-Mallat R, Morin C, Rousseau É. Novel n-3 PUFA monoacylglycerides of pharmacological and medicinal interest: anti-inflammatory and anti-proliferative effects . Eur J Pharmacol. 2016;792:70–7. doi:https://doi.org/10.1016/j.ejphar.2016.10.038
- Altenburg JD, Harvey KA, McCray S, Xu Z, Siddiqui RA. A novel 2,6-diisopropylphenyl-docosahexaenoamide conjugate induces apoptosis in T cell acute lymphoblastic leukemia cell lines . Biochem Biophys Res Commun. 2011;411(2):427–32. doi:https://doi.org/10.1016/j.bbrc.2011.06.172
- Bodkowski R, Patkowska-Sokola B, Filip-Psurska B, Kempinska K, Wietrzyk JA, et al. Evaluation of the antiproliferative activity of natural lipid preparations against tumor cell lines. J East Asian Stud. 2014;13:257–66.
- Fuentes NR, Kim E, Fan YY, Chapkin RS. Omega-3 fatty acids, membrane remodeling and cancer prevention. Mol Aspects Med. 2018;64:79–91. doi:https://doi.org/10.1016/j.mam.2018.04.001
- Johansson AS, Norén-Nystrom U, Larefalk A, Holmberg D, Lindskog M. Fish oil delays lymphoma progression in the TLL mouse. Leuk Lymphoma. 2010;51(11):2092–7. doi:https://doi.org/10.3109/10428194.2010.522284